MEDTRONIC PLC

MDT
Delayed Quote. Delayed  - 06/23 04:10:00 pm
125.49USD -0.98%
Income Statement Evolution
Annual Income Statement Data
Fiscal Period: December 2020 2021
Net sales1 28 91329 982
EBITDA1 8 4728 274
Operating profit (EBIT)1 7 5657 156
Operating Margin 26,2%23,9%
Pre-Tax Profit (EBT)1 4 0554 278
Net income1 4 7893 720
Net margin 16,6%12,4%
EPS2 3,542,74
Dividend per Share2 2,322,26
Announcement Date 05/21/2020-
1 USD in Million
2 USD
Previous periodNext period
Finances - Leverage
Fiscal Period: April 2020 2021
Net Debt1 20 65721 975
Net Cash position1 --
Leverage (Debt / EBITDA) 2,44x2,66x
Free Cash Flow1 6 0214 576
ROE (Net Profit / Equities) 12,3%11,7%
Shareholders' equity1 38 90331 743
ROA (Net Profit / Asset) 6,88%5,38%
Assets1 69 59869 172
Book Value Per Share2 37,837,8
Cash Flow per Share2 5,354,09
Capex1 1 2131 280
Capex / Sales 4,20%4,27%
Announcement Date 05/21/2020-
1 USD in Million
2 USD
Financial Ratios
Size 2021e 2022e
Capitalization 168 834 M $ -
Entreprise Value (EV) 190 809 M $ 189 629 M $
Valuation 2021e 2022e
P/E ratio (Price / EPS) 45,8x 30,0x
Capitalization / Revenue 5,63x 5,09x
EV / Revenue 6,36x 5,75x
EV / EBITDA 23,1x 18,7x
Yield (DPS / Price) 1,80% 1,92%
Price to book (Price / BVPS) 3,32x 3,21x
Profitability 2021e 2022e
Operating Margin (EBIT / Sales) 23,9% 27,6%
Operating Leverage (Delta EBIT / Delta Sales) - 2,62x
Net Margin (Net Profit / Revenue) 12,4% 17,2%
ROA (Net Profit / Asset) 5,38% 6,90%
ROE (Net Profit / Equities) 11,7% 14,4%
Rate of Dividend 82,6% 57,4%
Balance Sheet Analysis 2021e 2022e
CAPEX / Sales   4,27% 4,36%
Cash Flow / Sales 18,3% 21,9%
Capital Intensity (Assets / Sales) 2,31x 2,49x
Financial Leverage (Net Debt / EBITDA) 2,66x 2,04x
Price Earning Ratio
EPS & Dividend